首页> 外文期刊>Scientific reports. >Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin
【24h】

Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin

机译:ABCB1猪:分子克隆,组织分布,功能分析,其对恩诺沙星药代动力学效应

获取原文
       

摘要

P-glycoprotein (P-gp) is one of the best-known ATP-dependent efflux transporters, contributing to differences in pharmacokinetics and drug-drug interactions. Until now, studies on pig P-gp have been scarce. In our studies, the full-length porcine P-gp cDNA was cloned and expressed in a Madin-Darby Canine Kidney (MDCK) cell line. P-gp expression was then determined in tissues and its role in the pharmacokinetics of oral enrofloxacin in pigs was studied. The coding region of pig Abcb1 gene was 3,861?bp, encoding 1,286 amino acid residues (Mw?=?141,966). Phylogenetic analysis indicated a close evolutionary relationship between porcine P-gp and those of cow and sheep. Pig P-gp was successfully stably overexpressed in MDCK cells and had efflux activity for rhodamine 123, a substrate of P-gp. Tissue distribution analysis indicated that P-gp was highly expressed in brain capillaries, small intestine, and liver. In MDCK-pAbcb1 cells, enrofloxacin was transported by P-gp with net efflux ratio of 2.48 and the efflux function was blocked by P-gp inhibitor verapamil. High expression of P-gp in the small intestine could modify the pharmacokinetics of orally administrated enrofloxacin by increasing the Cmax, AUC and Ka, which was demonstrated using verapamil, an inhibitor of P-gp.
机译:P-糖蛋白(P-GP)是最着名的ATP依赖性流出转运蛋白之一,有助于药代动力学和药物 - 药物相互作用的差异。到目前为止,猪P-GP的研究一直很少。在我们的研究中,克隆全长猪P-GP cDNA并在Madin-Darby犬肾(MDCK)细胞系中表达。然后研究了P-GP表达,研究了在组织中,研究了猪中口腔氧氟沙星的药代动力学中的作用。猪ABCB1基因的编码区域为3,861bp,编码1,286个氨基酸残基(MW?= 141,966)。系统发育分析表明猪P-GP与牛和羊的近进进化关系。猪P-GP在MDCK细胞中成功过表达,并对罗丹明123的流出活性,P-GP的底物。组织分布分析表明,P-GP在脑毛细血管,小肠和肝脏中高度表达。在MDCK-PABCB1细胞中,通过P-GP通过P-GP运输苯甲酸氧化氟比净流出比为2.48,并且通过P-GP抑制剂维拉帕米阻断出流出函数。在小肠中的P-GP高表达可以通过增加使用维拉帕米(P-GP的抑制剂)证明的CMAX,AUC和Ka来修饰口服给予苯甲酸的药代动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号